End-Stage Renal Disease (ESRD): CMS Should Assess Adequacy of Payment When Certain Oral Drugs are Included and Ensure Availability of Quality Monitoring Data

Front Cover
DIANE Publishing, Jun 1, 2011 - 44 pages
0 Reviews
For most individuals with ESRD, Medicare purchases a bundle of dialysis-related services using a single payment. In 2014, CMS plans to include in this bundled payment "oral-only" ESRD drugs used to treat mineral and bone disorder. This report: (1) describes the rationales for including oral-only ESRD drugs in the bundled payment; (2) examines dialysis organizations' recent experience providing oral-only ESRD drugs and their future ability to provide these drugs; (3) examines the data sources that CMS could use to account for oral-only ESRD drugs in the bundled payment; and (4) examines CMS's ability to monitor treatment of mineral and bone disorder. Charts and tables. This is a print on demand edition of an important, hard-to-find report.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Common terms and phrases

Bibliographic information